Fannie Mae (FNMA) Fannie Mae provides liquidity and stability to the U.S. housing market by purchasing mortgages from lenders, enabling them to offer more loans. The company plays a critical role in financing affordable housing and supporting the mortgage industry. Chart Sana Biotechnology, Inc. (SANA) Sana Biotechnology, Inc. is a biotech company focused on developing […]
Read MoreFTAI Aviation Ltd. (FTAI) FTAI Aviation Ltd. specializes in acquiring, leasing, and managing aviation assets, including aircraft and engines. The company provides innovative solutions to airlines and operators, optimizing performance and cost-efficiency in the global aviation sector. Chart AngioDynamics, Inc. (ANGO) AngioDynamics, Inc. develops and markets innovative medical devices for minimally invasive treatment of vascular […]
Read MoreAeva Technologies, Inc. (AEVA) Aeva Technologies, Inc. develops advanced sensor technology for autonomous vehicles and industrial applications. Leveraging unique LiDAR capabilities, the company delivers 4D sensing solutions to enhance safety, precision, and automation across various sectors. Chart Eos Energy Enterprises, Inc. (EOSE) Eos Energy Enterprises, Inc. provides cutting-edge energy storage systems using its proprietary zinc […]
Read MoreThe RealReal, Inc. (REAL) The RealReal, Inc. operates as an online and brick-and-mortar marketplace for authenticated luxury consignment. Specializing in resale, the company connects buyers and sellers, promoting sustainable shopping while ensuring the authenticity of high-end fashion items. Chart Bridgetown Holdings Limited (BTNC) Bridgetown Holdings Limited operates as a special purpose acquisition company (SPAC), focusing […]
Read MoreOmeros Corporation (OMER) is a biopharmaceutical company focused on innovative therapies for unmet medical needs. Their work primarily revolves around developing and commercializing treatments in the areas of inflammation, immunology, and central nervous system disorders. The company’s flagship product, Omidria, is an FDA-approved drug used in cataract and lens replacement surgeries to prevent inflammation and […]
Read MoreOmeros Corporation (OMER) Omeros Corporation is a biopharmaceutical company focused on discovering and developing innovative therapeutics for diseases affecting the immune and central nervous systems. Their pipeline includes treatments for rare and serious conditions, addressing unmet medical needs. Chart Pulmatrix, Inc. (PULM) Pulmatrix, Inc. develops inhaled therapeutics designed to treat respiratory and other diseases. Leveraging […]
Read MoreThe biopharmaceutical and regenerative medicine industries are at the forefront of medical innovation, addressing critical healthcare challenges with advanced therapies. Omeros Corporation (OMER) is a leader in the biopharmaceutical space, focusing on treatments for inflammation, oncology, and rare diseases. Meanwhile, AVITA Medical, Inc. (RCEL) specializes in regenerative medicine, offering cutting-edge solutions for skin restoration and […]
Read MoreAligos Therapeutics, Inc. (ALGS) is a biopharmaceutical company dedicated to developing targeted therapies for viral and liver diseases. Their focus lies in addressing unmet medical needs, particularly in hepatitis B and non-alcoholic steatohepatitis (NASH). The company uses its proprietary technology platforms to create precision treatments that aim to improve patient outcomes significantly. Aligos’ core products […]
Read MoreDiaMedica Therapeutics Inc. (DMAC) is a biotechnology company that focuses on developing innovative treatments for neurological and kidney diseases. With a strong emphasis on unmet medical needs, DiaMedica is working to bring transformative solutions to patients who currently have limited options. Its flagship product, DM199, is a recombinant form of the KLK1 protein, aimed at […]
Read MoreAadi Bioscience, Inc. (AADI) is a pioneering biopharmaceutical company dedicated to developing precision therapies for rare cancers driven by specific genetic mutations. Its flagship product, FYARRO, is a novel mTOR inhibitor designed to target tumors with precision, focusing on patients who often have limited treatment options. FYARRO is already approved for treating advanced malignant PEComa […]
Read MoreDiaMedica Therapeutics Inc. (DMAC) DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for neurological and kidney diseases. Its innovative therapies target unmet medical needs to improve patient outcomes in these critical areas. Chart Scholar Rock Holding Corporation (SRRK) Scholar Rock Holding Corporation is a biopharmaceutical company developing therapies to treat serious […]
Read MoreInotiv, Inc. (NOTV) is a leading provider of preclinical and clinical contract research services. The company primarily focuses on the pharmaceutical, biotechnology, and medical device industries, offering a wide range of services that support drug development and testing. Inotiv specializes in toxicology testing, laboratory animal services, and drug discovery, helping their clients navigate the complexities […]
Read MoreBitSong (BTSG) BitSong is a blockchain-based platform designed to empower the music industry by enabling artists to distribute their work directly to listeners, bypassing traditional intermediaries. Utilizing decentralized technology, BitSong aims to create a more equitable ecosystem where artists retain greater control over their content and revenue streams. The platform offers features such as music […]
Read MoreArcutis Biotherapeutics, Inc. (ARQT) Arcutis Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing innovative therapies for dermatological diseases. The company’s lead product, ZORYVE® (roflumilast), is approved for the treatment of plaque psoriasis and atopic dermatitis. Arcutis emphasizes rapid relief and safety in its treatments, aiming to address unmet needs in dermatology. Chart FTAI […]
Read MoreMesoblast Limited (MESO) Mesoblast Limited is a biopharmaceutical company specializing in the development of allogeneic cellular medicines. The company’s proprietary mesenchymal lineage cell technology platform aims to treat complex diseases resistant to conventional therapies, including conditions like heart failure, chronic low back pain, and inflammatory diseases. Mesoblast focuses on advancing its pipeline through clinical trials […]
Read More